Vascular endothelial growth factor release from alginate microspheres under simulated physiological compressive loading and the effect on human vascular endothelial cells

Tissue Engineering - Part A

Volumn 17, Issue 13-14, 2011, Pages 1777-1785

  Li, Qiang ^a   Hou, Tianyong ^b   Zhao, Jianning ^a   Xu, Jianzhong ^b  

^a NANJING GENERAL HOSPITAL OF NANJING MILITARY COMMAND   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BEARINGS (MACHINE PARTS); BIOMATERIALS; BIOMECHANICS; BONE; COMPUTER SIMULATION; FRACTURE; INVESTMENTS; MICROSPHERES; PEPTIDES; PHOTOMASKS; POLYMER BLENDS; TISSUE; TISSUE ENGINEERING;

BONE DEFECT; BONE GRAFT; BONE TISSUE ENGINEERING; COMPRESSIVE LOADING; COMPRESSIVE LOADS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMAN VASCULAR ENDOTHELIAL CELLS; IN-VITRO; IN-VIVO; IN-VIVO EXPERIMENTS; LOAD-BEARING; MATRIX; MECHANICAL STIMULATION; NUTRIENT SUPPLY; RAPID DEGRADATION; RELEASE MEDIA; RELEASE PROFILES; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULARIZATION; VEGF RELEASE;

ENDOTHELIAL CELLS;

CAPRA HIRCUS;

ALGINIC ACID; GELATINASE A; GELATINASE B; GLUCURONIC ACID; HEXURONIC ACID; MICROSPHERE; POLYLYSINE; TISSUE SCAFFOLD; VASCULOTROPIN A;

ARTICLE; CELL CULTURE; CELL PROLIFERATION; CHEMISTRY; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM CELL; ENZYMOLOGY; HUMAN; MECHANICAL STRESS; SECRETION; UMBILICAL VEIN;

ALGINATES; CELL PROLIFERATION; CELLS, CULTURED; CULTURE MEDIA; ENDOTHELIAL CELLS; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICROSPHERES; POLYLYSINE; STRESS, MECHANICAL; TISSUE SCAFFOLDS; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79959555695     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0616     Document Type: Article

References (35)

1. Hou, T., Li, Q., Luo, F., Xu, J., Xie, Z., Wu, X., and Zhu, C. Controlled dynamization to enhance reconstruction capacity of tissue engineered bone in healing critically sized bone defects: An in vivo study in goats. Tissue Eng Part A 16, 201, 2010.
2. Zhang, X., Xie, C., Lin, A. S., Ito, H., Awad, H., Lieberman, J. R., Rubery, P. T., Schwarz, E. M., O'Keefe, R. J., and Guldberg, R. E. Periosteal progenitor cell fate in segmental cortical bone graft transplantations: implications for functional tissue engineering. J Bone Miner Res 20, 2124, 2005.
3. Viateau, V., Guillemin, G., Bousson, V., Oudina, K., Hannouche, D., Sedel, L., Logeart-Avramoglou, D., and Petite, H. Long-bone critical-size defects treated with tissueengineered grafts: a study on sheep. J Orthop Res 25, 741, 2010.
4. Kannan, R. Y., Salacinski, H. J., Sales, K., Butler, P., and Seifalian, A. M. The roles of tissue engineering and vascularisation in the development of micro-vascular networks: a review. Biomaterials 26, 1857, 2005.
5. Eckardt, H., Ding, M., Lind, M., Hansen, E. S., Christensen, K. S., and Hvid, I. Recombinant human vascular endothelial growth factor enhances bone healing in an experimental nonunion model. J Bone Joint Surg Br 87, 1434, 2005.
6. Kaigler, D., Wang, Z., Horger, K., Mooney, D. J., and Krebsbach, P. H. VEGF scaffolds enhance angiogenesis and bone regeneration in irradiated osseous defects. J Bone Miner Res 21, 735, 2006.
7. Street, J., Bao, M., de Guzman, L., Bunting, S., Peale, F. V., Jr., Ferrara, N., Steinmetz, H., Hoeffel, J., Cleland, J. L., Daugherty, A., van Bruggen, N., Redmond, H. P., Carano, R. A., and Filvaroff, E. H. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci U S A 99, 9656, 2002.
8. Kempen, D. H., Lu, L., Heijink, A., Hefferan, T. E., Creemers, L. B., Maran, A., Yaszemski, M. J., and Dhert, W. J. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials 30, 2816, 2009.
9. De la Riva, B., Sánchez, E., Hernández, A., Reyes, R., Tamimi, F., López-Cabarcos, E., Delgado, A., and Evora, C. Local controlled release of VEGF and PDGF from a combined brushite-chitosan system enhances bone regeneration. J Control Release1 43, 45, 2010.
10. Patel, Z. S., Young, S., Tabata, Y., Jansen, J. A., Wong, M. E., and Mikos, A. G. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 43, 931, 2008.
11. Young, S., Patel, Z. S., Kretlow, J. D., Murphy, M. B., Mountziaris, P. M., Baggett, L. S., Ueda, H., Tabata, Y., Jansen, J. A., Wong, M., and Mikos, A. G. Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defect model. Tissue Eng Part A 15, 2347, 2009.
12. Kanczler, J. M., Ginty, P. J., White, L., Clarke, N. M., Howdle, S. M., Shakesheff, K. M., and Oreffo, R. O. The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation. Biomaterials 31, 1242, 2010.
13. Tarkka, T., Sipola, A., Jämsä, T., Soini, Y., Ylä-Herttuala, S., Tuukkanen, J., and Hautala, T. Adenoviral VEGF-A gene transfer induces angiogenesis and promotes bone formation in healing osseous tissues. J Gene Med 5, 560, 2003.
14. Li, R., Stewart, D. J., von Schroeder, H. P., Mackinnon, E. S., and Schemitsch, E. H. Effect of cell-based VEGF gene therapy on healing of a segmental bone defect. J Orthop Res 27, 8, 2009.
15. Gu, F., Amsden, B., and Neufeld, R. Sustained delivery of vascular endothelial growth factor with alginate beads. J Control Release 96, 463, 2004.
16. Leach, J. K., Kaigler, D., Wang, Z., Krebsbach, P. H., and Mooney, D. J. Coating of VEGF releasing scaffolds with bioactive glass for angiogenesis and bone regeneration. Biomaterials 27, 249, 2006.
17. Zisch, A. H., Lutolf, M. P., and Hubbell, J. A. Biopolymeric delivery matrices for angiogenic growth factors. Cardiovasc Pathol 12, 295, 2003.
18. Davies, N., Dobner, S., Bezuidenhout, D., Schmidt, C., Beck, M., Zisch, A. H., and Zilla, P. The dosage dependence of VEGF stimulation on scaffold neovascularisation. Biomaterials 29, 3531, 2008.
19. Santos, M. I., and Reis, R. L. Vascularization in bone tissue engineering: physiology, current strategies, major hurdles and future challenges. Macromol Biosci 10, 12, 2010.
20. Ueng, S. W., Lee, S. S., Lin, S. S., Chan, E. C., Hsu, B. R., and Chen, K. T. Biodegradable alginate antibiotic beads. Clin Orthop Relat Res 380, 250, 2000.
21. Kleinheinz, J., Stratmann, U., Joos, U., and Wiesmann, H. P. VEGF activated angiogenesis during bone regeneration. J Oral Maxillofac Surg 63, 1310, 2005.
22. Jaffe, E. A., Nachman, R. L., Backer, C. G., and Minick, C. R. Culture of human endothelial cells derived from umbilical veins. 1. J Clin Invest 52, 2745, 1973.
23. Hou, T., Xu, J., Li, Q., Feng, J., and Zen, L. In vitro evaluation of a fibrin gel antibiotic delivery system containing mesenchymal stem cells and vancomycin alginate beads for treating bone infections and facilitating bone formation. Tissue Eng Part A 14, 1173, 2008.
24. Hou, T., Xu, J., Wu, X., Xie, Z., Luo, F., Zhang, Z., and Zen, L. Umbilical cord Wharton's Jelly: a new potential cell source of mesenchymal stromal cells for bone tissue engineering. Tissue Eng Part A 15, 2325, 2009.
25. Anderson, M. L., Dhert, W. J., de Bruijn, J. D., Dalmeijer, R. A., Leenders, H., van Blitterswijk, C. A., and Verbout, A. J. Critical size defect in the goat's os ilium. 1. Clin Orthop Relat Res 364, 231, 1999.
26. Kruyt, M. C., Dhert, W. J., Yuan, H., Wilson, C. E., van Blitterswijk, C. A., Verbout, A. J., and de Bruijn, J. D. Bone tissue engineering in a critical size defect compared to ectopic implantations in the goat. J Orthop Res 22, 544, 2004.
27. Sylven, C. Angiogenic gene therapy. Drugs Today 38, 819, 2002.
28. Gimbrone, M. A., Cotran, R. S., and Folkman, J. Human vascular endothelial cells in culture. 1. J Cell Biol 60, 673, 1974.
29. Ferrara, N., Gerber, H. P., and LeCouter, J. The biology of VEGF and its receptors. Nat Med 9, 669, 2003.
30. Ferrara, N., and Henzel, W. J. Pituitary follicular cells secrete anovel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161, 851, 1989.
31. Grasselli, F., Basini, G., Bussolati, S., and Tamanini, C. Effects of VEGF and bFGF on proliferation and production of steroids and nitric oxide in porcine granulosa cells. Reprod Domest Anim 37, 362, 2002.
32. Godin, D. Remodeling of carotid artery is associated with increased expression of matrix metalloproteinases in mouse blood flow cessation model. Circulation 102, 2861, 2000.
33. Moses, M. A. The regulation of neovascularization of matrix metalloproteinases and their inhibitors. Stem cells 15, 180, 1997.
34. Wang, Y., Chang, J., Li, Y. C., Li, Y. S., Shyy, J. Y., and Chien, S. Shear stress and VEGF activate IKK via the Flk-1/Cbl/Akt signaling pathway. Am J Physiol Heart Circ Physiol 286, H685, 2004.
35. Li, S., Kim, M., Hu, Y. L., Jalali, S., Schlaepfer, D. D., Hunter, T., Chien, S., and Shyy, J. Y. 1. Linking to mitogen-activated protein kinases. J Biol Chem 272, 30455, 1997.